CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
- DOI
- 10.1186/s12885-021-08758-9
- Published
- 2021 Sep 25
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-021-08758-9,
title = {CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.},
author = {Coquan E and Brachet PE and Licaj I and Leconte A and Castera M and Lequesne J and Meriaux E and Bonnet I and Lelaidier A and Clarisse B and Joly F},
year = {2021},
journal = {BMC cancer},
doi = {10.1186/s12885-021-08758-9},
url = {https://doi.org/10.1186/s12885-021-08758-9}
}RIS
TY - JOUR TI - CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure. AU - Coquan E AU - Brachet PE AU - Licaj I AU - Leconte A AU - Castera M AU - Lequesne J AU - Meriaux E AU - Bonnet I AU - Lelaidier A AU - Clarisse B AU - Joly F PY - 2021 JO - BMC cancer DO - 10.1186/s12885-021-08758-9 UR - https://doi.org/10.1186/s12885-021-08758-9 ER -
APA
E, C., PE, B., I, L., A, L., M, C., J, L., E, M., I, B., A, L., B, C., & F, J. (2021). CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.. BMC cancer. https://doi.org/10.1186/s12885-021-08758-9
Source records
- pubmed · retrieved 2026-09-27T13:06:58.886Z